Clinical Trial Update: A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years

View source ↗

Summary

A longitudinal clinical trial sponsored by Sanofi Pasteur studies Epstein-Barr virus (EBV) reactivation in healthy adults ages 18 to 29, with status not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus Infection

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Epstein-Barr Virus (EBV), Healthy Volunteers | Status: NOT_YET_RECRUITING